Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
03:59am, Wednesday, 11'th Oct 2023
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
Here's Why You Should Retain Fresenius Medical (FMS) for Now
09:46am, Friday, 15'th Sep 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical's (FMS) New HHD Device to Increase Portability
09:46am, Thursday, 24'th Aug 2023
Fresenius Medical (FMS) gets FDA clearance for Versi HD with GuideMe Software, a portable, home hemodialysis device with an easy-to-use graphical interface providing easier training experiences.
Fresenius Medical (FMS) Q2 Earnings and Revenues Beat Estimates
12:00pm, Thursday, 03'rd Aug 2023
Fresenius Medical's (FMS) second-quarter revenues benefit from strong performance across all segments. Inflationary pressure continues to improve, benefiting operating income.
Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2023 Earnings Call Transcript
03:47pm, Wednesday, 02'nd Aug 2023
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q2 2023 Earnings Conference Call August 2, 2023 9:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Helen Giza - Chief Executive
Fresenius Medical Care: Heads Don't Roll - They Run
08:30am, Thursday, 27'th Jul 2023
Fresenius Medical Care is the world's leading full-service provider of dialysis care and benefits from the entire value chain thanks to its vertical integration. Despite its market-leading position, F
Why Shares of Fresenius Medical Jumped This Week
02:32pm, Friday, 14'th Jul 2023
The move is meant to allow better and timelier decision-making. Fresenius operates dialysis facilities across the world.
Fresenius Medical shareholders approve change in legal form
09:54am, Friday, 14'th Jul 2023
Fresenius Medical Care said on Friday that shareholders voted with a 99.88% majority in favour of a change that will simplify its governance and make parent Fresenius SE a regular minority shareholder
Fresenius Medical Care shares drop on U.S. dialysis payment adjustment
03:27am, Tuesday, 27'th Jun 2023
Shares in kidney dialysis group Fresenius Medical Care declined 1.7% at market open in Germany on Tuesday after a payment increase proposed by a major U.S. public health insurance body fell short of m
Fresenius Medical Care: Other Stocks Still Better, But Upside Exists
12:41pm, Thursday, 01'st Jun 2023
Fresenius Medical Care has shown some improvement in recent trends, but still faces headwinds and pressures in its markets. Analysts have consistently underestimated FMS's performance, and I think the
Fresenius Medical (FMS) Q1 Earnings and Revenues Beat Estimates
12:55pm, Wednesday, 10'th May 2023
Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.
Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat
02:45pm, Thursday, 23'rd Feb 2023 Zacks Investment Research
Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
10:53am, Thursday, 23'rd Feb 2023 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
American Well Corporation (NYSE: AMWL) shares fell 10.8% to $3.23 in
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
06:01pm, Wednesday, 22'nd Feb 2023
Dear Investor:
Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call Transcript
12:37pm, Wednesday, 22'nd Feb 2023
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q4 2022 Earnings Conference Call February 22, 2023 9:30 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chair & Chief
